home / stock / tcon / tcon news


TCON News and Press, TRACON Pharmaceuticals Inc. From 03/14/24

Stock Information

Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: NASDAQ
Website: traconpharma.com

Menu

TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...

TCON - US Companies Moving the Markets, Evening edition
Thu, Mar 14, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 51.9% to $0.1549 on volume of 312,863,578 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.4% to $3.51 on volume of 229,852,079 shares SoundHound AI Inc. (SOUN) fell 3.2% to $8.37 on volu...

TCON - TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript

2024-03-05 22:37:19 ET TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Conference Call March 5, 2024 16:30 ET Company Participants Charles Theuer - President & Chief Executive Officer Scott Brown - Chief Financial Officer Conference Call Participants ...

TCON - Tracon GAAP EPS of -$0.01 beats by $0.06, revenue of $3M beats by $1.5M

2024-03-05 16:04:24 ET More on Tracon Seeking Alpha’s Quant Rating on Tracon Historical earnings data for Tracon Financial information for Tracon Read the full article on Seeking Alpha For further details see: Tracon GAAP EPS of -$0.01 beat...

TCON - TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other li...

TCON - Expected US Company Earnings on Tuesday, March 5th, 2024

Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...

TCON - TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024

SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other lif...

TCON - TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial

Objective Response Rate by investigator review increased to 15% since interim analysis in September Full ENVASARC enrollment expected in 1Q 2024 and final data anticipated during 3Q 2024 SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical...

TCON - 24/7 Market News Snapshot 22 Nov 2023

2023-11-22 09:57:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ESGL Holdings Ltd (NASDAQ: ESGL), SciSparc Ltd (NASDAQ: SPRC), Safety Shot Inc (NASDAQ: SHOT), PaxMedica Inc ...

TCON - 24/7 Market News Snapshot 21 Nov 2023

2023-11-21 10:05:00 ET DENVER, Colo., Nov. 21, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Anghami Inc (NASDAQ: ANGH), ABVC BioPharma Inc (NASDAQ: ABVC), Can Fite Biofarma Ltd (AMEX: CANF), Altamira T...

TCON - TRACON announces license of product development platform for $3M upfront payment

2023-11-20 08:45:48 ET More on Tracon TRACON Pharmaceuticals, Inc. (TCON) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Tracon Historical earnings data for Tracon Financial information for Tracon For further details see: ...

Previous 10 Next 10